P
IRMD icon

&Partners’s iRadimed IRMD Stock Holding History

&Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+2,106
New +$192K ﹤0.01% 2384

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

&Partners's IRMD Position: Q2 2026 in Review

&Partners opened a new position in iRadimed (IRMD) in Q2 2026: 2,106 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #2384 among its holdings.

214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • &Partners held 2,106 shares of iRadimed worth $201K as of Q2 2026.
  • iRadimed was a new &Partners position in Q2 2026.
  • iRadimed made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2384 holding.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.